Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma

NCT02443077

Clinical Trial Information


Trial Number: NCT02443077 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
Trial Title:
"A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype"
Study ID:
A051301
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT03914625

Clinical Trial Information


Trial Number: NCT03914625 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Leukemia - Acute Lymphoblastic Leukemia
  • Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
Trial Title:
"A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)"
Study ID:
AALL1731
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT03213678

Clinical Trial Information


Trial Number: NCT03213678 (ClinicalTrials.gov)
Disease Type:
  • CNS Neoplasm (Primary Tumor) - Miscellaneous
  • CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
  • Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
  • Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"NCI-COG Pediatric MATCH (Molecular Analysis For Therapy Choice)- Phase 2 Subprotocol of LY3023414 in Patients With Solid Tumors"
Study ID:
APEC1621D
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT03526250

Clinical Trial Information


Trial Number: NCT03526250 (ClinicalTrials.gov)
Disease Type:
  • CNS Neoplasm (Primary Tumor) - Miscellaneous
  • CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
  • Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
  • Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Palbociclib in Patients With Tumors Harboring Activating Alterations in Cell Cycle Genes"
Study ID:
APEC1621I
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT03220035

Clinical Trial Information


Trial Number: NCT03220035 (ClinicalTrials.gov)
Disease Type:
  • CNS Neoplasm (Primary Tumor) - Miscellaneous
  • CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
  • Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
  • Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Vemurafenib in Patients With Tumors Harboring BRAF V600 Mutations"
Study ID:
APEC1621G
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT03233204

Clinical Trial Information


Trial Number: NCT03233204 (ClinicalTrials.gov)
Disease Type:
  • CNS Neoplasm (Primary Tumor) - Miscellaneous
  • CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
  • Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
  • Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- A Phase 2 Subprotocol of Olaparib in Patients With Tumors Harboring Defects in DNA Damage Repair Genes"
Study ID:
APEC1621H
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT03698994

Clinical Trial Information


Trial Number: NCT03698994 (ClinicalTrials.gov)
Disease Type:
  • CNS Neoplasm (Primary Tumor) - Miscellaneous
  • CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
  • Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
  • Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of BVD-523FB (Ulixertinib) in Patients With Tumors Harboring Activating MAPK Pathway Mutations"
Study ID:
APEC1621J
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT03213665

Clinical Trial Information


Trial Number: NCT03213665 (ClinicalTrials.gov)
Disease Type:
  • CNS Neoplasm (Primary Tumor) - Miscellaneous
  • CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
  • Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
  • Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Tazemetostat in Patients With Tumors Harboring Alterations in EZH2 or Members of the SWI/SNF Complex"
Study ID:
APEC1621C
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT03213691

Clinical Trial Information


Trial Number: NCT03213691 (ClinicalTrials.gov)
Disease Type:
  • CNS Neoplasm (Primary Tumor) - Miscellaneous
  • CNS-excluded Nervous System Neoplasm and Disorder - Neuroblastoma
  • Hematopoietic Neoplasm (excluding Leukemia, Lymphoma and Myeloma) - Miscellaneous
  • Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
  • Miscellaneous Neoplasm - Solid Tumor
Trial Title:
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Selumetinib (AZD6244 Hydrogen Sulfate) in Patients With Tumors Harboring Activating MAPK Pathway Mutations
Study ID:
APEC1621E
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT02112916

Clinical Trial Information


Trial Number: NCT02112916 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Leukemia - Acute Lymphoblastic Leukemia
  • Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
Trial Title:
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Study ID:
AALL1231
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

Title Description
NCT02112916-D2 NCT02112916-D2: There are two data submissions for PMID 35271306. This dataset, NCT02112916-D2, provides specific incidence of adverse events in interest, as presented in Supplemental Table 15 “Toxicity Comparison AALL1231 vs AALL0434” . It includes patients enrolled on COG study AALL1231 and AALL0434 who experienced targeted grade 3+ adverse events. The data cutoff is 09/30/2021.
NCT02112916-D1 NCT02112916-D1: There are two data submissions for PMID 35271306. This dataset, NCT02112916-D1, provides the information presented in all tables, figures, and numbers in the manuscript, except for Supplemental Table 15 . It includes all patients who enrolled on COG study AALL1231 and AALL0434. There is one row for each patient enrolled. The data cutoff is 09/30/2021.
Subscribe to Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma

Accessibility  |  Disclaimer  |  FOIA  |  HHS Vulnerability Disclosure  |  Privacy & Security

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®